Drug intelligence / Profile preview

Inhibitor Q8467

Development stage: Unknown
Lead developer: Bristol Myers Squibb
Modality: Small Molecules

Overview

Inhibitor Q8467 is a chemical compound with the formula C34H36N4O4S, identified by CID 448069, that was developed by DuPont Merck Pharmaceutical Company. Specific details regarding its mechanism of action, primary indication, and development status are not publicly available. It is presumed to be an early-stage research compound.

Other names: INHIBITOR Q8467 OF DUPONT MERCKCID 448069CID448069CID-448069

Targets

PR (Progesterone receptor)

Beyond the preview

Go deeper on Inhibitor Q8467.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inhibitor Q8467.

Explore the full profile